On Friday, Ronald Levy, the Tokyo Olympic 110m hurdles bronze medallist from Jamaica, was handed a four-year ban by the Jamaica Anti-Doping Commission (JADCO) following a positive test for banned substances.
The substance detected in Levy’s sample, taken during an out-of-competition test in October 2023, was GW1516. This black-market drug is known for enhancing endurance and increasing the body’s ability to burn fat, allowing users to train harder and longer. However, GW1516 has not been approved for human use due to concerns about its potential cancer risks and other severe long-term health effects.
Levy said on social media that he was shocked at the positive test result, maintaining he did not knowingly violate any rules: “I am stunned by this turn of events because I have always conducted myself with the highest level of integrity in the sport, which I love dearly, and would never seek to gain an unfair advantage.”
The 31-year-old hurdler won bronze at the Tokyo 2020 Olympics behind American Grant Holloway and Levy’s fellow Jamaican, Hansle Parchment. He also won gold in the 110m hurdles at the 2018 Commonwealth Games. Levy has not competed since September 2023 and did not qualify for the 2024 Paris Olympics.
🗣️ Lest you forget!
Tokyo 2020*, The first time Jamaica had two men on the podium at the Olympics in 110mh!
Hansle Parchment, Gold (13.04)
Ronald Levy, Bronze (13.10) pic.twitter.com/etzW1j8rYh— Dav (@ideekhayy) October 29, 2023
Levy has the right to appeal the decision and take his case to the Court of Arbitration for Sport (CAS). While a successful appeal could overturn the ban, the process could also result in significant financial and physical strain if the appeal is unsuccessful. This is the third high-profile GW1516 case in the past two years, following the positive tests of former Olympic 800m silver medallist Nijel Amos of Botswana and Surinamese sprinter Issam Asinga, the U20 100m record holder. Both men tested positive during out-of-competition tests.
